Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from Sacklers
Purdue Pharma has submitted its latest opioid lawsuit settlement plan, including up to $7 billion cash from the Sackler family.
Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that would have members of the Sackler family who own the company pay up to $7 billion.
The filing is a milestone in a tumultuous legal saga that has gone on for more than five years.
